Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gary Onik is a specialized medical practice and clinical research entity focused on advanced interventional oncology. Founded by Dr. Gary Onik, a pioneer in cryosurgery, the organization specializes in the treatment of recurrent and inoperable cancers using innovative focal therapies. The core of the practice is the Immunocryoablation protocol, which combines cryoablation with the direct injection of immunotherapeutic agents to trigger a systemic immune response against metastatic disease. Additionally, the entity provides 3D Prostate Mapping Biopsy services, a technique developed by Dr. Onik to improve the precision of prostate cancer diagnosis and treatment. The practice primarily serves patients with prostate, liver, and pancreatic cancers who have failed standard-of-care treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gary Onik.